Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 12 | -420K | 100% | $93.31 | -$39.2M |
Net | -12 | -420K | -100% | -$39.2M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Kate Haviland | Chief Executive Officer | $13.9M | -$1.13M | -7.52% | Mar 7, 2024 |
Jeffrey W. Albers | Director | $13.4M | -$9.29M | -40.9% | Sep 9, 2024 |
Christina Rossi | Chief Operating Officer | $8.22M | -$550K | -6.28% | Jul 1, 2024 |
Alexis Borisy | Director | $7.8M | Jun 12, 2024 | ||
Michael Landsittel | Chief Financial Officer | $6.4M | -$4.02M | -38.6% | Aug 15, 2024 |
Fouad Namouni | President, R & D | $6.17M | -$721K | -10.5% | Oct 3, 2024 |
Nicholas Lydon | Director | $6.1M | Jun 12, 2024 | ||
Percy H. Carter | Chief Scientific Officer | $5.49M | -$887K | -13.9% | Jul 1, 2024 |
Tracey L. McCain | Evp And Chief Legal Officer | $5.49M | -$471K | -7.91% | Mar 7, 2024 |
Debra Durso-Bumpus | Chief People Officer | $4.87M | -$9.62M | -66.4% | Jul 3, 2024 |
Philina Lee | Chief Commercial Officer | $3.24M | -$4.9M | -60.2% | Aug 5, 2024 |
L. Becker Hewes | Chief Medical Officer | $3.1M | -$4.67M | -60.1% | Jun 4, 2024 |
Christopher K. Murray | Chief Technical Operations | $3.07M | -$1.24M | -28.7% | Mar 7, 2024 |
Mark Alan Goldberg | Director | $1.92M | Jun 12, 2024 | ||
Ariel Hurley | Principal Accounting Officer | $1.59M | -$1.74M | -52.3% | May 15, 2024 |
Lynn Seely | Director | $1.39M | Jun 12, 2024 | ||
Lonnel Coats | Director | $1.39M | Jun 12, 2024 | ||
Daniella Beckman | Director | $1.14M | Jun 12, 2024 | ||
Habib J. Dable | Director | $919K | Jun 12, 2024 | ||
John Tsai | Director | $919K | Jun 12, 2024 | ||
George Demetri | Director | $757K | Jun 21, 2022 | ||
Charles A. Rowland Jr | Director | $523K | Jun 2, 2021 | ||
Tango Therapeutics, Inc. | Director | $306K | Dec 8, 2021 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|